Company: RNAC
Filing Date: 2025-10-30
Form Type: 8-K
Source: 0001140361-25-039793
Chunk: 1

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-10-30
Form: 8-K
Item: Item 5.03
Chunk 1
---
Item 5.03      Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.  

On October 29, 2025, the Board approved an amendment and restatement of the Company’s Amended and Restated Bylaws, which became effective the same
day. The Amended and Restated Bylaws now include appropriate references to the position of Lead Independent Director of the Board.

The preceding summary of the Amended and Restated Bylaws is qualified in its entirety by reference to, and should be read in connection with, the
complete copy of the Amended and Restated Bylaws attached to this Current Report on Form 8-K as Exhibit 3.2 and incorporated by reference herein.

  Item 7.01      Regulation FD Disclosure.